692 related articles for article (PubMed ID: 32503256)
41. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
42. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
[TBL] [Abstract][Full Text] [Related]
43. Emerging agents that target signaling pathways to eradicate colorectal cancer stem cells.
Silva VR; Santos LS; Dias RB; Quadros CA; Bezerra DP
Cancer Commun (Lond); 2021 Dec; 41(12):1275-1313. PubMed ID: 34791817
[TBL] [Abstract][Full Text] [Related]
44. MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer.
Liu X; Fu Q; Du Y; Yang Y; Cho WC
Curr Cancer Drug Targets; 2016; 16(9):738-754. PubMed ID: 26577538
[TBL] [Abstract][Full Text] [Related]
45. Molecular Biomarkers and Signaling Pathways of Cancer Stem Cells in Colorectal Cancer.
Omran MM; Fouda MS; Mekkawy SA; Tabll AA; Abdelaziz AG; Omran AM; Emran TM
Technol Cancer Res Treat; 2024; 23():15330338241254061. PubMed ID: 38794896
[TBL] [Abstract][Full Text] [Related]
46. An miRNA Expression Signature for the Human Colonic Stem Cell Niche Distinguishes Malignant from Normal Epithelia.
Viswanathan V; Damle S; Zhang T; Opdenaker L; Modarai S; Accerbi M; Schmidt S; Green P; Galileo D; Palazzo J; Fields J; Haghighat S; Rigoutsos I; Gonye G; Boman BM
Cancer Res; 2017 Jul; 77(14):3778-3790. PubMed ID: 28487386
[TBL] [Abstract][Full Text] [Related]
47. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
48. miR-613 inhibits liver cancer stem cell expansion by regulating SOX9 pathway.
Li B; Liu D; Yang P; Li HY; Wang D
Gene; 2019 Jul; 707():78-85. PubMed ID: 31075412
[TBL] [Abstract][Full Text] [Related]
49. Role and molecular mechanism of stem cells in colorectal cancer initiation.
Wang MY; Qiu YH; Cai ML; Zhang CH; Wang XW; Liu H; Chen Y; Zhao WL; Liu JB; Shao RG
J Drug Target; 2020 Jan; 28(1):1-10. PubMed ID: 31244351
[TBL] [Abstract][Full Text] [Related]
50. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
Song L; Li Y; He B; Gong Y
Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
[TBL] [Abstract][Full Text] [Related]
51. TFAP2C promotes stemness and chemotherapeutic resistance in colorectal cancer via inactivating hippo signaling pathway.
Wang X; Sun D; Tai J; Chen S; Yu M; Ren D; Wang L
J Exp Clin Cancer Res; 2018 Feb; 37(1):27. PubMed ID: 29439714
[TBL] [Abstract][Full Text] [Related]
52. Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells.
Paquet-Fifield S; Koh SL; Cheng L; Beyit LM; Shembrey C; Mølck C; Behrenbruch C; Papin M; Gironella M; Guelfi S; Nasr R; Grillet F; Prudhomme M; Bourgaux JF; Castells A; Pascussi JM; Heriot AG; Puisieux A; Davis MJ; Pannequin J; Hill AF; Sloan EK; Hollande F
Cancer Res; 2018 Jun; 78(11):2925-2938. PubMed ID: 29510994
[TBL] [Abstract][Full Text] [Related]
53. Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells.
Bose D; Zimmerman LJ; Pierobon M; Petricoin E; Tozzi F; Parikh A; Fan F; Dallas N; Xia L; Gaur P; Samuel S; Liebler DC; Ellis LM
Br J Cancer; 2011 Nov; 105(11):1759-67. PubMed ID: 22045189
[TBL] [Abstract][Full Text] [Related]
54. Eliminating Cancer Stem-Like Cells in Oral Cancer by Targeting Elementary Signaling Pathways.
Joshi J; Patel H; Bhavnagari H; Tarapara B; Pandit A; Shah F
Crit Rev Oncog; 2022; 27(4):65-82. PubMed ID: 37199303
[TBL] [Abstract][Full Text] [Related]
55. Revolutionizing colorectal cancer treatment: unleashing the potential of miRNAs in targeting cancer stem cells.
Osei GY; Adu-Amankwaah J; Koomson S; Beletaa S; Ahmad MK; Asiamah EA; Smith-Togobo C; Abdul Razak SR
Future Oncol; 2023 Nov; 19(35):2369-2382. PubMed ID: 37970643
[TBL] [Abstract][Full Text] [Related]
56. GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism.
Zhang S; Chatterjee T; Godoy C; Wu L; Liu QJ; Carmon KS
Mol Cancer Res; 2019 Nov; 17(11):2196-2207. PubMed ID: 31444231
[TBL] [Abstract][Full Text] [Related]
57. Knockdown of hnRNPAB reduces the stem cell properties and enhances the chemosensitivity of human colorectal cancer stem cells.
Zhou J; Chen S; Liu J; Du J; Li J
Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37165920
[TBL] [Abstract][Full Text] [Related]
58. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.
Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W
J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383
[TBL] [Abstract][Full Text] [Related]
59. Cancer stem cells in colorectal cancer: a review.
Munro MJ; Wickremesekera SK; Peng L; Tan ST; Itinteang T
J Clin Pathol; 2018 Feb; 71(2):110-116. PubMed ID: 28942428
[TBL] [Abstract][Full Text] [Related]
60. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities.
Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B
J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
